Pizotifen
1-Methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidine
Drag to rotate. Structure from PubChem CID 27400.
Background
Listing
- Schedules
- Schedule 2 to 5, conditions apply
- Source
- Consolidated Schedules 06 July 2026
Registered medicines
The ingredient index links no registered medicine to Pizotifen (register of 13 September 2026).
Counted through the register's ingredient index, which does not reach every record.
Regulatory status
Where S2 to S5 sits on the scale
Depends on which listing applies
At the least restrictive, Schedule 2: a pharmacist can sell it directly, without a prescription. At the most restrictive, Schedule 5: prescription-only, with tighter controls on repeats. The listings below say which applies to which form, strength or pack size.
Schedule S2 to S5, as the Consolidated Schedules list it.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Pizotifen
S5: Pizotifen
- except preparations and mixtures thereof when used solely as an antihistaminic or when intended for the prophylaxis of migraine. (S2)
Consolidated Schedules 06 July 2026, lines 9649 to 9650
S2: Pizotifen
- preparations and mixtures, when intended for prophylaxis of migraine.
Consolidated Schedules 06 July 2026, line 2549
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.